Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Lumos Pharma
Lumos Pharma
Actuate Therapeutics Inc.
Eisai Inc.
Vividion Therapeutics, Inc.
Inhibrx Biosciences, Inc
UNICANCER
National University Hospital, Singapore
Nurix Therapeutics, Inc.
DEKA Biosciences
Jazz Pharmaceuticals
Eli Lilly and Company
AbbVie
Sumitomo Pharma America, Inc.
Fudan University
Indiana University
Blokhin's Russian Cancer Research Center
Shenzhen Hornetcorn Bio-technology Company, LTD
City of Hope Medical Center
Hanmi Pharmaceutical Company Limited
GlaxoSmithKline
Seattle Cancer Treatment and Wellness Center